By Korea Basic Science Institute
Development of diagnostic and therapeutic technologies through the discovery and validation of therapeutic targets related to diseases (cancer, metabolic diseases, and infectious diseases) using AI and multi-omics convergence technologies Establishment of a personalized therapy–toxicity evaluation platform by integrating human-derived 3D models with single-cell omics analysis, thereby strengthening innovative drug development capabilities and providing research support
